Palatin Technologies, Inc. (AMEX:PTN)
| CAPS Rating |
|
|---|---|
| Open | $0.67 |
| Previous Close | $0.68 |
| Daily Range | $0.63 - $0.68 |
| 52-Week Range | $0.39 - $1.38 |
| Market Cap | $23.03M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 61,344 |
| Average Daily Volume | 0 |
PTN
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PTN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PTN News and Commentary
- The 10 Most-Watched Diagnostic Substances Stocks – The Motley Fool
- Palatin Technologies CEO Discusses F3Q2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Palatin Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Palatin Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript – SeekingAlpha
- Palatin Technologies CEO Discusses F1Q2011 Results - Earnings Call Transcript – SeekingAlpha
- Palatin Technologies CEO Discusses F1Q2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Novartis to Pay $422.5 Million to Settle Allegations: Biotech's Latest Tribulations – SeekingAlpha
- Palatin CEO Discusses F4Q2010 Results - Earnings Call Transcript – SeekingAlpha
- Palatin CEO Discusses F4Q2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Palatin Tech 4Q Loss Widens Sharply As Revenue Plunges – SmartMoney
- P&G Patches Up Sex Life? – The Motley Fool
Related News and Articles
- Illuminating the Way Forward for Genomics – The Motley Fool
- When Passing Your Clinical Trial Isn't Enough – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- Life Technologies' Sequence of Success – The Motley Fool
- Is Avanir Pharmaceuticals the Perfect Stock? – The Motley Fool
- Can Amgen Convince Docs to Recommend Approval? – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
RSS Headlines
Fool UK
